A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol

Introduction The clinical interpretation of laboratory tests is reliant on reference intervals. However, the accuracy of a reference interval is dependent on the selected reference population, and in paediatrics, the ability of the reference interval to reflect changes associated with growth and age...

Full description

Saved in:
Bibliographic Details
Main Authors: Susan M Donath, Monsurul Hoq, Vicky Karlaftis, Susan Mathews, Janet Burgess, John Carlin, Paul Monagle, Vera Ignjatovic
Format: Article
Language:English
Published: BMJ Publishing Group 2019-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/4/e025897.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823857276367142912
author Susan M Donath
Monsurul Hoq
Vicky Karlaftis
Susan Mathews
Janet Burgess
John Carlin
Paul Monagle
Vera Ignjatovic
author_facet Susan M Donath
Monsurul Hoq
Vicky Karlaftis
Susan Mathews
Janet Burgess
John Carlin
Paul Monagle
Vera Ignjatovic
author_sort Susan M Donath
collection DOAJ
description Introduction The clinical interpretation of laboratory tests is reliant on reference intervals. However, the accuracy of a reference interval is dependent on the selected reference population, and in paediatrics, the ability of the reference interval to reflect changes associated with growth and age, as well as sex and ethnicity. Differences in reagent formulations, methodologies and analysers can also impact on a reference interval. To date, no direct comparison of reference intervals for common analytes using different analysers in children has been published. The Harmonising Age Pathology Parameters in Kids (HAPPI Kids) study aims to establish age-appropriate reference intervals for commonly used analytes in the routine clinical care of neonates and children, and to determine the feasibility of paediatric reference interval harmonisation by comparing age-appropriate reference intervals in different analysers for multiple analytes.Methods and analysis The HAPPI Kids study is a prospective cross-sectional study, collecting paediatric blood samples for analysis of commonly requested biochemical, immunological and haematological tests. Venous blood samples are collected from healthy premature neonates (32–36 weeks of gestation), term neonates (from birth to a maximum of 72 hours postbirth) and children aged 30 days to ≤18 years (undergoing minor day surgical procedures). Blood samples are processed according to standard laboratory procedures and, if not processed immediately, stored at –80°C. A minimum of 20 samples is analysed for every analyte for neonates and then each year of age until 18 years. Analytical testing is performed according to the standard operating procedures used for clinical samples. Where possible, sample aliquots from the same patients are analysed for an analyte across multiple commercially available analysers.Ethics and dissemination The study protocol was approved by The Royal Children’s Hospital, Melbourne, Ethics in Human Research Committee (34183 A). The study findings will be published in peer-reviewed journals and shared with clinicians, laboratory scientists and laboratories.
format Article
id doaj-art-521549691dee433c9e1d1adfc0ac3677
institution Kabale University
issn 2044-6055
language English
publishDate 2019-04-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-521549691dee433c9e1d1adfc0ac36772025-02-11T22:50:08ZengBMJ Publishing GroupBMJ Open2044-60552019-04-019410.1136/bmjopen-2018-025897A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocolSusan M Donath0Monsurul Hoq1Vicky Karlaftis2Susan Mathews3Janet Burgess4John Carlin5Paul Monagle6Vera Ignjatovic7Clinical Epidemiology and Biostatistics Unit, Murdoch Childrens Research Institute, Melbourne, Victoria, AustraliaClinical Epidemiology and Biostatistics, Murdoch Children`s Research Institute, Parkville, Victoria, Australia3 Department of Haematology Research, Murdoch Children’s Research Institute, Parkville, Victoria, Australia4 Department of Biochemistry, Laboratory Services, The Royal Children’s Hospital, Parkville, Victoria, Australia5 Department of Pathology Collection, Laboratory Services, The Royal Children’s Hospital, Parkville, Victoria, Australia1 Department of Paediatrics, The University of Melbourne, Parkville, Australia2 Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia6 Institute for Clinical and Translational Research, Johns Hopkins All Children`s Hospital, St Petersburg, Florida, USAIntroduction The clinical interpretation of laboratory tests is reliant on reference intervals. However, the accuracy of a reference interval is dependent on the selected reference population, and in paediatrics, the ability of the reference interval to reflect changes associated with growth and age, as well as sex and ethnicity. Differences in reagent formulations, methodologies and analysers can also impact on a reference interval. To date, no direct comparison of reference intervals for common analytes using different analysers in children has been published. The Harmonising Age Pathology Parameters in Kids (HAPPI Kids) study aims to establish age-appropriate reference intervals for commonly used analytes in the routine clinical care of neonates and children, and to determine the feasibility of paediatric reference interval harmonisation by comparing age-appropriate reference intervals in different analysers for multiple analytes.Methods and analysis The HAPPI Kids study is a prospective cross-sectional study, collecting paediatric blood samples for analysis of commonly requested biochemical, immunological and haematological tests. Venous blood samples are collected from healthy premature neonates (32–36 weeks of gestation), term neonates (from birth to a maximum of 72 hours postbirth) and children aged 30 days to ≤18 years (undergoing minor day surgical procedures). Blood samples are processed according to standard laboratory procedures and, if not processed immediately, stored at –80°C. A minimum of 20 samples is analysed for every analyte for neonates and then each year of age until 18 years. Analytical testing is performed according to the standard operating procedures used for clinical samples. Where possible, sample aliquots from the same patients are analysed for an analyte across multiple commercially available analysers.Ethics and dissemination The study protocol was approved by The Royal Children’s Hospital, Melbourne, Ethics in Human Research Committee (34183 A). The study findings will be published in peer-reviewed journals and shared with clinicians, laboratory scientists and laboratories.https://bmjopen.bmj.com/content/9/4/e025897.full
spellingShingle Susan M Donath
Monsurul Hoq
Vicky Karlaftis
Susan Mathews
Janet Burgess
John Carlin
Paul Monagle
Vera Ignjatovic
A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol
BMJ Open
title A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol
title_full A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol
title_fullStr A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol
title_full_unstemmed A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol
title_short A prospective, cross-sectional study to establish age-specific reference intervals for neonates and children in the setting of clinical biochemistry, immunology and haematology: the HAPPI Kids study protocol
title_sort prospective cross sectional study to establish age specific reference intervals for neonates and children in the setting of clinical biochemistry immunology and haematology the happi kids study protocol
url https://bmjopen.bmj.com/content/9/4/e025897.full
work_keys_str_mv AT susanmdonath aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT monsurulhoq aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT vickykarlaftis aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT susanmathews aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT janetburgess aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT johncarlin aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT paulmonagle aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT veraignjatovic aprospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT susanmdonath prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT monsurulhoq prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT vickykarlaftis prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT susanmathews prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT janetburgess prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT johncarlin prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT paulmonagle prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol
AT veraignjatovic prospectivecrosssectionalstudytoestablishagespecificreferenceintervalsforneonatesandchildreninthesettingofclinicalbiochemistryimmunologyandhaematologythehappikidsstudyprotocol